Atossa Therapeutics, Inc.
ATOSCIK 0001488039 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 25, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:Mild positive shiftFull-doc fallback
Full filing:tone -0.0177Δ+0.001286% similar+338/-288 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Atossa Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Steinhart Richard I | Director | 5 |
| Weaver Gregory L | OfficerDirector | 5 |
| Cigler Tessa | Director | 4 |
| Daniel Mark James | Officer | 2 |
| Guse Kyle | Officer | 2 |
All filings
50 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|